Related Experiment Video
Updated: Aug 10, 2026
07:47
Experimental Human Pneumococcal Carriage
Published on: February 15, 2013
Pneumococcal vaccination in splenectomised cancer patients
Aurelius G Omlin1, Kathrin Mühlemann, Martin F Fey
1Department of Medical Oncology, University Hospital, 3010 Bern, Switzerland.
European Journal of Cancer (Oxford, England : 1990)
|July 20, 2005
Summary
Pneumococcal vaccination rates in cancer patients who have undergone splenectomy have improved, but remain suboptimal. Targeted interventions are crucial, especially for young Hodgkin lymphoma patients, to ensure adequate vaccination coverage.
Area of Science:
- Oncology
- Immunology
- Public Health
Background:
- Pneumococcal vaccination is recommended for splenectomized patients.
- Vaccination rates in this population have historically been unsatisfactory.
Purpose of the Study:
- To assess pneumococcal vaccination rates in splenectomized cancer patients.
- To evaluate changes in vaccination coverage over time.
Main Methods:
- Retrospective assessment of vaccination status in splenectomized cancer patients.
- Comparison of data from two consecutive assessments.
Main Results:
- Pneumococcal vaccination coverage increased from 59.7% to 75% in splenectomized cancer patients.
- 20% of patients remained unvaccinated.
- Vaccination rates in Hodgkin lymphoma patients rose significantly from 40% to 93%.
Conclusions:
- Despite improvements, pneumococcal vaccination coverage in splenectomized cancer patients requires further enhancement.
- Young patients with Hodgkin lymphoma are a key at-risk group for insufficient vaccination.
- Repeated assessments and interventions can improve vaccination rates.
Related Concept Videos
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:30Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia V: Nursing management and Prevention
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
01:27Pneumothorax-II
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...